|
|
Volumn 60, Issue 4, 2003, Pages
|
|
Recap of FDA product approvals - 2002
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ATOMOXETINE;
DIPHTHERIA PERTUSSIS TETANUS VACCINE;
EXTRANEAL;
FULVESTRANT;
IBRITUMOMAB TIUXETAN;
NEW DRUG;
NITAZOXANIDE;
NITISINONE;
ORPHAN DRUG;
OXALIPLATIN;
OXYBATE SODIUM;
PEDIARIX;
RASBURICASE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
TEGASEROD;
UNCLASSIFIED DRUG;
UNIPROST;
VACCINE;
ATTENTION DEFICIT DISORDER;
DRUG APPROVAL;
DRUG INDICATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IRRITABLE COLON;
LICENSING;
MALIGNANT NEOPLASTIC DISEASE;
NOTE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
ARTICLE;
DRUG MANUFACTURE;
NEOPLASM;
UNITED STATES;
ARTHRITIS, RHEUMATOID;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
COLONIC DISEASES, FUNCTIONAL;
DRUG APPROVAL;
HUMANS;
NEOPLASMS;
ORPHAN DRUG PRODUCTION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VACCINES;
|
|
EID: 0037631865
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/60.4.310 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|